Hemodiyaliz Hastalarında Leptin Parametreleri Enflamasyon ve Protein- Enerji Kaybının Serum ve Antropometrik Göstergeleri ile İlişkilidir

1. Bergstrom J: Why are dialysis patients malnourished? Am J Kidney
Dis 1995; 26: 229-241
2. Carrero JJ, Chmielewski M, Axelsson J, Snaedal S, Heimbürger
O, Bárány P, Suliman ME, Lindholm B, Stenvinkel P, Qureshi AR:
Muscle atrophy, inflammation and clinical outcome in incident and
prevalent dialysis patients. Clin Nutr 2008; 27: 557-564
3. Mak RH, Cheung W, Cone RD, Marks DL: Leptin and inflammationassociated
cachexia in chronic kidney disease. Kidney Int 2006;
69(5): 794-797
4. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen
FT, Bihain BE, Lodish HF: Proteolytic cleavage product of 30-kDa
adipocyte complement-related protein increases fatty acid oxidation
in muscle and causes weight loss in mice. Proc Natl Acad Sci USA
2001; 98: 2005-2010
5. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL,
Chen CL, Tai TY, Chuang LM: Weight reduction increases plasma
levels of an adipose-derived anti-inflammatory protein, adiponectin.
J Clin Endocrinol Metab 2001; 86: 3815-38196. Qi Y, Takahashi N, Hileman SM, Patel HR, Berg AH, Pajvani UB,
Scherer PE, Ahima RS: Adiponectin acts in the brain to decrease
body weight. Nat Med 2004; 10: 524-529
7. Stenvinkel P, Lindholm B, Lönnqvist F, Katzarski K, Heimbürger
O: Increases in serum leptin levels during peritoneal dialysis are
associated with inflammation and a decrease in lean body mass. J
Am Soc Nephrol 2000; 11: 1303-1309
8. Daschner M, Tönshoff B, Blum WF, Englaro P, Wingen AM,
Schaefer F, Wühl E, Rascher W, Mehls O: Inappropriate elevate
of serum leptin in children with chronic renal failure. European
Study Group for Nutritional Treatment of Chronic Renal Failure in
Childhood. J Am Soc Nephrol 1998; 9: 1074-1079
9. Young GA, Woodrow G, Kendall S, Oldroyd B, Turney JH,
Brownjohn AM, Smith MA: Increased plasma leptin/fat ratio in
patients with chronic renal failure: A cause of malnutrition? Nephrol
Dial Transplant 1997; 12(11): 2318-2323
10. Carrero JJ, Brodin L, Lindholm B, Stenvinkel P: Adiponectin in
chronic kidney disease: Dr Jekyll and Mr Hyde. Kidney Int 2009;
75: 120-121
11. Shamsuzzaman AS, Winnicki M, Wolk R, Svatikova A, Phillips
BG, Davison DE, Berger PB, Somers VK: Independent association
between plasma leptin and CRP in healthy humans. Circulation
2004; 109: 2181-2185
12. Ble A, Windham BG, Bandinelli S, Taub DD, Volpato S, Bartali B,
Tracy RP, Guralnik JM, Ferrucci L: Relation of plasma leptin to
C-reactive protein in older adults. Am J Cardiol 2005; 96: 991-995
13. Maachi M, Piéroni L, Bruckert E, Jardel C, Fellahi S, Hainque B,
Capeau J, Bastard JP: Systemic low-grade inflammation is related to
both circulating and adipose tissue TNFα, leptin and IL-6 levels in
obese women. nt J Obes Relat Metab Disord 2004; 28 (8): 993-997
14. Monzillo LU, Hamdy O, Horton ES, Ledbury S, Mullooly C,
Jarema C, Porter S, Ovalle K, Moussa A, Mantzoros CS: Effect of
lifestyle modification on adipokine levels in obese subjects with
insulin resistance. Obes Res 2003; 11(9): 1048-1054
15. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB:
Plasma adiponectin levels and risk of myocardial infarction in men.
JAMA 2004; 291: 1730-1737
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF,
Turner RC: Homeostasis model assessment: Insulin resistance
and beta-cell function from fasting plasma glucose and insulin
concentrations in man. Diabetologia 1985; 28: 412-419
17. Kalantar-Zadeh K, Kleiner M, Dunne E, Lee GH, Luft FC:
A modified quantitative subjective global assessment of nutrition
for dialysis patients. Nephrol Dial Transplant 1999; 14 (7): 1732-
173818. Konstantinides S, Schafer K, Koschnick S, Loskutoff DJ: Leptindependent
platelet aggregation and arterial thrombosis suggests a
mechanism for atherothrombotic disease in obesity. J Clin Invest
2001; 108(10): 1533-1540
19. Parhami F, Tintut Y, Ballard A, Fogelman AM, Demer LL: Leptin
enhances the calcification of vascular cells artery wall as a target of
leptin. Circ Res 2001; 88 (9): 954-960
20. Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ,
Klein AS, Bulkley GB, Bao C, Noble PW, Lane MD, Diehl AM:
Leptin regulates proinflammatory immune responses. FASEB J
1998;12 (1): 57-65
21. Dowidar NL, Dejong CHC, Fearon KCH, Garden OJ, Ross JA:
Effects of leptin on isolated human hepatocyte C reactive protein
production. Eur J Gastroenterol Hepatol 2000; 12: A18
22. Nordfors L, Lönnqvist F, Heimbürger O, Danielsson A, Schalling
M, Stenvinkel P: Low leptin gene expression and hyperleptinemia
in chronic renal failure. Kidney Int 1998; 54: 1267-1275
23. Pecoits-Filho R, Nordfors L, Heimbürger O, Lindholm B, Anderstam
B, Marchlewska A, Stenvinkel P: Soluble leptin receptors and serum
leptin in end-stage renal disease: relationship with inflammation and
body composition. Eur J Clin Invest 2002; 32: 811-817
24. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K:
Adiponectin and adiponectin receptors in insulin resistance,
diabetes, and the metabolic syndrome. J Clin Invest 2006; 116 (7):
1784-1792
25. Guebre-Egziabher F, Bernhard J, Funahashi T, Hadj-Aissa A,
Fouque D: Adiponectin in chronic kidney disease is related more
to metabolic disturbances than to decline in renal function. Nephrol
Dial Transplant 2005; 20: 129-134
26. Shen YY, Charlesworth JA, Kelly JJ, Loi KW, Peake PW: Upregulation
of adiponectin, its isoforms and receptors in end-stage
kidney disease. Nephrol Dial Transplant 2007; 22(1): 171-178
27. Wiecek A, Adamczak M, Chudek J: Adiponectin-an adipokine with
unique metabolic properties. Nephrol Dial Transplant 2007; 22:
981-988
28. Yilmaz MI, Saglam M, Qureshi AR, Carrero JJ, Caglar K, Eyileten
T, Sonmez A, Cakir E, Oguz Y, Vural A, Yenicesu M, Stenvinkel P,
Lindholm B, Axelsson J: Endothelial dysfunction in type-2 diabetics
with early diabetic nephropathy is associated with low circulating
adiponectin. Nephrol Dial Transplant 2008; 23: 1621-1627